Scinai Immunotherapeutics Ltd ADR (SCNI) Stock Price, Quote & News

Company Profile

Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis. The company also offers contract development and manufacturi...

Industry: Biotechnology

Sector: Healthcare

Phone: 972 8 930 2529

Fax: 972 8 930 2531

Website: www.scinai.com

Address:

Jerusalem BioPark, 2nd Floor Hadassah Ein Kerem Campus, Jerusalem, Israel

Richard_Roma Jul. 1 at 6:02 PM

$SCNI is representive of Independence Day, as making people independent of their money. Predict another reverse split incoming soon lest this turd gets delisted to the pinksheets.

0 · Reply

Richard_Roma Jun. 30 at 1:56 PM

$SCNI execs will never let go of their salary, as long as long-term bagholders starting switch to no-name cat food to get those 100 shares purchases.

0 · Reply

Ditchg Jun. 27 at 9:38 PM

$SCNI I’m just hear for the @Richard_Roma comments. Funny shit. Been dropping the bangors for years now hahahahahaha

0 · Reply

CrumbEater Jun. 25 at 5:37 PM

$SCNI lets see .01

0 · Reply

luckysupernova Jun. 23 at 8:35 PM

$SCNI how can it be in the .20s... who issues shares to dump yhem in the .20s.. crazy. So no catalyst, i think we know whats next.

1 · Reply

Richard_Roma Jun. 23 at 6:18 PM

$SCNI what you mean is your hoping there is a bigger sucker to take this loss off your hands 💩

0 · Reply

keilee Jun. 23 at 1:34 PM

$SCNI volume is coming in !!! Get here

0 · Reply

keilee Jun. 23 at 12:51 PM

$SCNI I’m in … I have faith 💪🏽💪🏽

0 · Reply

Richard_Roma Jun. 17 at 4:51 PM

$SCNI "enhancing compensation"? This Israeli bioturd is only good at enriching executive compensation while failing shareholders This The agenda includes re-electing board members, increasing authorized ordinary shares, amending and enhancing compensation arrangements for CEO Amir Reichman and Chairman Mark Germain, and ratifying Ziv Haft of BDO as the company’s auditor, steps that underscore Scinai’s efforts to strengthen governance, secure additional share capacity, and align leadership incentives with long-term performance.

1 · Reply